SynthesisInternational urology and nephrology2024

Renal, cardiovascular, and safety outcomes of adding sodium-glucose cotransporter-2 inhibitors to insulin therapy in patients with type-2 diabetes: a meta-analysis.

Qian Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.